Contribute Try STAT+ Today

14apr11:00 amThe Biotech SPAC-tacular: Reshaping the way health care thinks about fundingVirtual Hosted by: Demy-Colton

Hosted by

Demy-Colton

Event Details

Sponsored by Bloomberg, join us for a complimentary fireside chat with Brent Saunders, CEO, Vesper Healthcare Acquisition Corp. and former CEO of Allergan, Forest Laboratories and Bausch + Lomb!

In the past 12-16 months, special purpose acquisition companies, better known as “SPACs” have been making headlines for their high profile, value, and sometimes very sudden entrance to the public markets. Investor interest in biotech & pharma remains hot, whether via SPACs or other funding models, which begs the question: what’s driving all the action, and what does it mean for biotech & pharma companies?

On April 14th we welcome Brent Saunders, CEO, Vesper Healthcare Acquisition Corp. and former CEO of Allergan, Forest Laboratories and Bausch + Lomb for a conversation with Ann-Hunter Van Kirk, Senior BioPharma Equity Analyst, Bloomberg Intelligence, to get their first-hand experience with SPACs and what it means for a company to garner interest from the investment community.

Time

Apr. 14, 11 a.m.-12 p.m.

Location

Virtual